Products of AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals is a biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.

The Company has three commercial products: Feraheme®, Feridex I.V.® and GastroMARK®.

Feraheme® (ferumoxytol) Injection

Feraheme is indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease.

Read the Press Release announcing U.S. Marketing approval of Feraheme. Download the Feraheme Package Insert.

Feraheme is being developed to treat iron deficiency anemia associated with other conditions and disease states including women with abnormal uterine bleeding, and patients with cancer and gastrointestinal diseases.

Feraheme is also being developed as a diagnostic agent for vascular-enhanced magnetic resonance imaging to assess peripheral arterial disease.

For more information, please visit www.feraheme.com.

Feridex®

Feridex I.V.® (ferumoxides) is AMAG Pharmaceuticals' contrast agent for use with magnetic resonance imaging (MRI) for the detection of liver lesions. In November 2008, the Company ceased manufacturing of Feridex and does not intend to continue its commercialization. The Company has terminated agreements with all of our Feridex marketing partners including Bayer Healthcare Pharmaceuticals and TaeJoon Pharmaceuticals Co., Ltd.

GastroMARK®

GastroMARK® (ferumoxsil) is AMAG Pharmaceuticals' oral gastrointestinal (GI) imaging agent for delineation of the bowel. Images of organs and tissues in the abdomen using MRI without contrast agents can be difficult to read because the abdominal organs and tissues cannot be easily distinguished from the loops of the bowel. GastroMARK® flows through and darkens the bowel when ingested. By more clearly identifying the intestinal loops, GastroMARK® enhances ability to distinguish the bowel from adjacent tissues and organs in the upper gastrointestinal tract.

AMAG Pharmaceuticals, Feraheme, and the AMAG logos are trademarks of AMAG Pharmaceuticals, Inc. Feraheme and Feridex I.V. are trademarks of AMAG Pharmaceuticals, Inc. registered in the U.S. and other countries. GastroMARK is a trademark of Mallinckrodt Inc. (a subsidiary of Covidien, Ltd.) registered in the U.S. Lumirem is a trademark of Guerbet S.A.